Kimia Biosciences Closes Trading Window for Q1 FY27 Results

Kimia Biosciences Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is effective from July 1, 2026, and will continue until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. The measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be closed for all promoters, directors, designated persons, and their immediate relatives. The company will separately announce the date of the Board of Directors' meeting to consider these financial results.